Literature DB >> 21196233

Signalling pathways and vascular calcification.

Yiwen Liu1, Catherine M Shanahan.   

Abstract

Vascular calcification is a major risk factor for cardiovascular morbidity and mortality. A full understanding of the signalling pathways mediating vascular calcification is crucial not just because of the importance of this pathology in disease, but also for exploring potential therapeutic targets. Clinically there is a need to develop therapies to prevent or even reverse calcification in situations of atherosclerosis, chronic kidney disease, diabetes, and aging. In this brief review, we intend to explore the initial triggers, which are commonly related to calcification in different disease scenarios and examine the downstream signalling pathways that instigate the process of vascular calcification. In particular, we try to dissect these pathways and also examine cross-talk between different signalling pathways. Our focus is the vascular smooth muscle cell (VSMC) as it is ultimately the phenotypic modulation of these cells that may drive the calcification process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196233     DOI: 10.2741/3790

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  28 in total

1.  CKD-mineral and bone disorder: core curriculum 2011.

Authors:  Ranjani N Moorthi; Sharon M Moe
Journal:  Am J Kidney Dis       Date:  2011-10-21       Impact factor: 8.860

Review 2.  Fibroblast growth factor signaling in the vasculature.

Authors:  Xuehui Yang; Lucy Liaw; Igor Prudovsky; Peter C Brooks; Calvin Vary; Leif Oxburgh; Robert Friesel
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

Review 3.  RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy.

Authors:  Agbor Ndip; Fiona L Wilkinson; Edward B Jude; Andrew J M Boulton; M Yvonne Alexander
Journal:  Diabetologia       Date:  2014-08-12       Impact factor: 10.122

Review 4.  The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.

Authors:  David D McManus; Jane S Saczynski; Jeanine A Ward; Khushleen Jaggi; Peter Bourrell; Chad Darling; Robert J Goldberg
Journal:  J Atr Fibrillation       Date:  2012-06-15

5.  Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model.

Authors:  Marta Scatena; Melissa F Jackson; Mei Y Speer; Elizabeth M Leaf; Mary C Wallingford; Cecilia M Giachelli
Journal:  Cardiovasc Pathol       Date:  2018-02-15       Impact factor: 2.185

Review 6.  BMPs and their clinical potentials.

Authors:  Meejung Kim; Senyon Choe
Journal:  BMB Rep       Date:  2011-10       Impact factor: 4.778

Review 7.  Vitamin K status and vascular calcification: evidence from observational and clinical studies.

Authors:  M Kyla Shea; Rachel M Holden
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

8.  One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility.

Authors:  Raziye Mohammadpour; Darwin L Cheney; Jason W Grunberger; Mostafa Yazdimamaghani; Jolanta Jedrzkiewicz; Kyle J Isaacson; Marina A Dobrovolskaia; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2020-05-25       Impact factor: 9.776

Review 9.  Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy.

Authors:  N L Petrova; C M Shanahan
Journal:  Osteoporos Int       Date:  2013-10-03       Impact factor: 4.507

Review 10.  Mechanisms of vascular calcification in CKD-evidence for premature ageing?

Authors:  Catherine M Shanahan
Journal:  Nat Rev Nephrol       Date:  2013-09-10       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.